Adult minimal-change disease: observational data from a UK centre on patient characteristics, therapies, and outcomes

Predictors of Relapse in Adult-Onset Nephrotic Minimal Change Disease

(2016) Hajeong Lee et al.   MEDICINE

Long-Term Prognosis of Adult Patients with Steroid-Dependent Minimal Change Nephrotic Syndrome Following Rituximab Treatment

(2015) Yuko Iwabuchi et al.   MEDICINE

Rituximab Treatment for Relapsing Minimal Change Disease and Focal Segmental Glomerulosclerosis: A Systematic Review

(2014) Andreas Kronbichler et al.   AMERICAN JOURNAL OF NEPHROLOGY

Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease

(2013) Helene Munyentwali et al.   KIDNEY INTERNATIONAL

Rituximab for minimal change disease in adults: long-term follow-up

(2013) A. Bruchfeld et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Notice

(2012)   Kidney International Supplements

Rituximab in adult patients with immunosuppressive-dependent minimal change disease

(2011) E. Hoxha et al.   CLINICAL NEPHROLOGY

Membranous nephropathy remains the commonest primary cause of nephrotic syndrome in a northern European Caucasian population

(2009) E. P. McQuarrie et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION